Brian Schryver

Astero Bio Corp. develops novel tools and technologies for the life science research, pharmaceutical manufacturing and clinical applications. It specializes in the development and commercialization of next-generation tools to aid in multiple stages of the lifecycles of biologics. The firm’s products include ThawSTAR CB, ThawSTAR AT6, ThawSTAR CFT2, ThawSTAR CFT2 confirmation vials, IOP qualification packet, BioT ULT transporter, BioT LN2 transporter, and BioT mobile workstation. The company was founded by Samuel Kent in 2018 and is headquartered in Menlo Park, CA.

BioCision LLC operates as a life science research and development company. Its products include cell cryopreservation systems, sample cooling, freezing, snap-freezing, ice-free cooling systems, tube temperature and plate temperature management, support platforms, sample transport, cryostorage boxes, cryogenic vials, ice pans and buckets and other accessories. The firm’s products protect temperature-sensitive therapeutics, biological samples and biomaterials. The company was founded by Brian Schryver and Rolf O. Ehrhardt in 2007 and is headquartered in San Rafael, CA.

CFD Therapeutics, Inc. (CFD), is being created to develop novel cancer therapeutics stemming from discoveries made previously by diaDexus. CFD will specifically focus on the development of therapeutic monoclonal antibodies directed against proprietary ovarian, pancreatic, breast, colon, prostate and lung cancer targets licensed from diaDexus. diaDexus, Inc. and San Francisco-based Biotechnology Value Fund L.P